Clinical Trials Browser

Phase 2 × Stomach Neoplasms × neratinib × Clear all

NCT06109467 2026-02-09

Neratinib In Combination With Chemotherapy/Trastuzumab/Pembrolizumab In HER2 Gastroesophageal Cancer

Phase 2 Recruiting

Gastrointestinal

Stomach Neoplasms